LHCG LHC Group Inc.

LHC Group and Erlanger Health System Finalize Joint Venture Agreement

LHC Group (NASDAQ: LHCG) and Erlanger Health System today announced finalization of a new joint venture to enhance home health and community-based services in Chattanooga and southeast Tennessee. The joint venture includes a Chattanooga facility providing both skilled home health care and non-skilled community-based services, further expanding LHC Group’s joint venture presence and services footprint in the state of Tennessee.

LHC Group is purchasing majority ownership of the facility in Chattanooga and assuming management responsibility. The facility will operate under the name Erlanger ContinuCare Home Health. LHC Group expects annualized revenue from this joint venture of approximately $7 million and that it will not materially affect its 2017 diluted earnings per share.

“Our organizations share a commitment to delivering the highest quality care while helping patients recover in the comfort of home and preventing costly and avoidable hospital readmissions,” said Keith G. Myers, LHC Group’s chairman and CEO. “LHC Group has a proven history of successful hospital partnerships that are enhancing post-acute care for patients around the nation. Erlanger Health System is recognized for its commitment to the health and well-being of its patients and their families. We are proud to partner with Erlanger Health System to deliver superior home health services to the people of southeast Tennessee, and we welcome our Erlanger colleagues into the LHC Group family.”

“LHC Group, like the Erlanger Health System, is recognized as a leader across the country for its community-based services,” said Donna Bourdon, Erlanger vice president and president of ContinuCare HealthServices, Inc. “It is a great pleasure to enter into this strategic partnership with LHC Group for the provision of home health services based on a common mission of quality, service, and compassionate care. As we team up to expand our home health services for infants, children, and adults, we also look to improve the health of our community, reduce length of stay and avoidable readmissions, and get our patients safely back to their homes.”

Based in Chattanooga, Erlanger Health System is a multi-hospital system with five hospitals: the Baroness Hospital, Children's Hospital at Erlanger, Erlanger North Hospital, Erlanger East Hospital, and Erlanger Bledsoe Hospital. It is a Level I Trauma Center, providing the highest level of trauma care for adults. Erlanger is also an academic teaching hospital through its affiliation with the University of Tennessee College of Medicine Chattanooga.

Hospital and home health partnerships focused on delivering patient-centered care in the comfort of the patient’s home are increasingly a key component in helping patients manage their conditions and achieve the best possible health. LHC Group is the joint venture partner of choice and partners with 75 health systems consisting of more than 250 hospitals across the United States.

About LHC Group, Inc.

LHC Group, Inc. is a national provider of non-acute healthcare services, providing quality, cost-effective healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice, community-based services, and facility-based services.

About Erlanger Health System

The Erlanger Health System has five Tennessee-based medical hospitals and six emergency departments, including the region’s only children’s hospital and Level I Trauma Center, providing the highest level of trauma care. Affiliated with the University of Tennessee College of Medicine Chattanooga, Erlanger is also the region’s only academic teaching center and treats more than a quarter million patients every year.

EN
04/12/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LHC Group Inc.

LHC GROUP reduces its risk exposure and slightly improves to Neutral

The independent financial analyst theScreener just allocated a lower risk rating to LHC GROUP (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly improved and can be qualified as moderately risky. theScreener considers that these elements merit an overall rating upgrade to Neutral. As of the analysis date April 1, 2022, the closing price was USD 168.13 and its expect...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - D2021 10 12

LPL Financial (LPLA) has created a powerful platform to empower independent and smaller scale wealth advisors to compete with the big players like Merrill Lynch and Morgan Stanley. Uniform Accounting highlights the company's operational improvements that the market is missing, indicating equity upside. AMD Q2 2021 Embedded Expectations Analysis – Market expectations are for Uniform ROA to expand, but management may have concerns about data center revenue growth, EPYC processors, and operating c...

Valens Research
  • Valens Research

LHCG - Embedded Expectations Analysis - 2021 10 11

LHC Group, Inc. (LHCG:USA) currently trades around corporate averages relative to UAFRS-based (Uniform) earnings, with a 24.4x Uniform P/E, implying bullish expectations for the firm. However, management may have concerns about staffing challenges, cost management, and admissions growth. Specifically, management may lack confidence in their ability to gain stronger physician support for taking higher acuity patients into the home, forecast patient volumes and characteristics, and sustain organi...

LHC Group Inc: 1 director

A director at LHC Group Inc sold 5,000 shares at 201.620USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

LHC Group to present at the Baird 2020 Global Healthcare Conference

LHC Group to present at the Baird 2020 Global Healthcare Conference LAFAYETTE, La., Sept. 08, 2020 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020. The presentation will begin at 8:30 a.m. Eastern time, and a live will be available. To access the live webcast, listeners should go to the section of the Company’s website, , approximately 15 minutes prior to the event to register and download any necessary software. About LHC Group, Inc.LHC Group, Inc. is a nat...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch